RAMP vs CDLX

For growth investors, LiveRamp Holdings, Inc.

(RAMP) is the stronger pick with 13. 0% revenue growth year-over-year, versus -16. 2% for Cardlytics, Inc. (CDLX). Analysts rate LiveRamp Holdings, Inc. (RAMP) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, LiveRamp Holdings, Inc.

(RAMP) delivered a total return of -37. 0%, compared to -99. 2% for Cardlytics, Inc. (CDLX). Over 10 years, the gap is even starker: RAMP returned +34. 8% versus CDLX's -93. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), LiveRamp Holdings, Inc.

(RAMP) is the lower-risk stock at 0. 97β versus Cardlytics, Inc. 's 3. 18β — meaning CDLX is approximately 230% more volatile than RAMP relative to the S&P 500.

By revenue growth (latest reported year), LiveRamp Holdings, Inc.

(RAMP) is pulling ahead at 13. 0% versus -16. 2% for Cardlytics, Inc. (CDLX). On earnings-per-share growth, the picture is similar: Cardlytics, Inc. grew EPS 50. 1% year-over-year, compared to -107. 1% for LiveRamp Holdings, Inc.. Over a 3-year CAGR, RAMP leads at 12. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

LiveRamp Holdings, Inc.

(RAMP) is the more profitable company, earning -0. 1% net margin versus -44. 4% for Cardlytics, Inc. — meaning it keeps -0. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RAMP leads at 0. 7% versus -20. 2% for CDLX. At the gross margin level — before operating expenses — RAMP leads at 71. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, LiveRamp Holdings, Inc.

(RAMP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 97)). Cardlytics, Inc. (CDLX) carries a higher beta of 3. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RAMP: +34. 8%, CDLX: -93. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (RAMP (Technology) and CDLX (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.